(Q41040677)

26 September 2017

Monoclonal antibody-standardized cat extract immunotherapy: risk-benefit effects from a double-blind placebo study (English)

1 reference

26 September 2017

0 references

1 reference

E Alvarez-Cuesta

1

1 reference

26 September 2017

J Cuesta-Herranz

2

1 reference

26 September 2017

J Puyana-Ruiz

3

1 reference

26 September 2017

C Cuesta-Herranz

4

1 reference

26 September 2017

A Blanco-Quirós

5

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 March 1994

1 reference

The Journal of Allergy and Clinical Immunology

26 September 2017

1 reference

26 September 2017

93

1 reference

26 September 2017

3

1 reference

26 September 2017

556-566

1 reference

The problem of furred pets in childhood atopic disease. Failure of an information program

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Pet sensitivities in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Skin prick test reactivity to common allergens in Finnish adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

The frequency and severity of cat allergy vs. dog allergy in atopic children

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Antigenic analysis of household dust samples

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Airborne cat allergen (Fel d I). Environmental control with the cat in situ.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Immunotherapy in cat-induced asthma *1Double-blind trial with evaluation of bronchial responses to cat allergen and histamine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Immunotherapy for cat asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Immunotherapy with partially purified and standardized animal dander extracts. I. Clinical results from a double-blind study on patients with animal dander asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Characterization of the main IgE-binding components of cat dander

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Studies on the biochemical structure of the major cat allergen Felis domesticus I

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Monoclonal antibodies against Fel d I and other clinically relevant cat allergens

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Monoclonal antibody based radioimmunoassay for the quantitation of the main cat allergen (Fel d I or Cat-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

A controlled study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Environmental control of indoor air pollution

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Dust mites: immunology, allergic disease, and environmental control.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

The control of allergens of dust mites and domestic pets: a position paper

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Activity units for allergen extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Pharmacological influence of antiallergic medication on in vivo allergen testing

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

The precision of the conjunctival provocation test

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Standardization of Allergens: Lectins and Monoclonal Antibodies as Primary Standards for House Dust Mite Allergens

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Standardization of allergens. Examination of existing procedures and the likely impact of new techniques on the quality control of extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Immunotherapy with dog and cat extracts in children

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Dose of cat (Felis domesticus) allergen 1 (Fel d 1) that induces asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Prospective study on immunologic changes induced by two different Dermatophagoides pteronyssinus extracts prepared from whole mite culture and mite bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

Responses to ragweed-pollen nasal challenge before and after immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970067-2

7 January 2021

10.1016/S0091-6749(94)70067-2

Identifiers

DOI

1 reference

26 September 2017

1 reference